Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2010
07/29/2010DE112008001879T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu irer Herstellung Plants having enhanced yield characteristics and methods of manufacture IRER
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/29/2010CA2750584A1 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
07/29/2010CA2750581A1 Pta089 protein
07/29/2010CA2750561A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010CA2749789A1 Method for temporally controlling the biological activity of proteins in vertebrates, and applications thereof
07/29/2010CA2749539A1 Compositions and methods of treating inflammatory and autoimmune diseases
07/29/2010CA2749298A1 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010CA2748873A1 Methods and compositions based on shiga toxin type 2 protein
07/29/2010CA2748689A1 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010CA2748506A1 Novel bacillus thuringiensis gene with lepidopteran activity
07/29/2010CA2747825A1 Stable growth hormone compounds
07/28/2010EP2211176A2 Analyzing nerve cell damage
07/28/2010EP2210948A2 Use of multiple recombination sites with unique specificity in recombinational cloning
07/28/2010EP2210947A2 Method for producing secreted proteins
07/28/2010EP2210946A1 Mutant of the proB gene from coryneform bacteria
07/28/2010EP2210945A2 Neisseria meningitidis antigens
07/28/2010EP2210940A1 Method for high-level secretion and production of protein
07/28/2010EP2210900A2 Analogues of GLP-1
07/28/2010EP2210899A1 pntr transcription factor
07/28/2010EP2210898A1 Bacillus Licheniformis chromosome
07/28/2010EP2210617A1 Mammalian cells secreting Neurturin and their therapeutic use
07/28/2010EP2210611A1 Use of the sequence encoding the carboxyl-terminal domain of the heavy chain of tetanus toxin as a drug
07/28/2010EP2210105A1 Mycobacterium antigens
07/28/2010EP2209908A1 Recombinant factor viii having increased stability
07/28/2010EP2209899A1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate
07/28/2010EP2209892A2 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same
07/28/2010EP2209810A1 Viral therapeutic
07/28/2010EP2209805A1 An antigen associated with rheumatoid arthritis
07/28/2010EP2209801A2 Manufacture, compositions and uses of coagulationfactor viia modulator
07/28/2010EP2209800A2 Pharmaceutical compositions comprising glp-1 peptides or exendin-4 and a basal insulin peptide
07/28/2010EP2209799A2 Breast cancer associated antigen
07/28/2010EP2209798A2 Modified growth hormone polypeptides
07/28/2010EP2209797A2 Modification of intrinsically disordered sequences for preparing vaccines
07/28/2010EP1891210B1 Dengue serotype 2 attenuated strain
07/28/2010EP1606317B1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
07/28/2010EP1421199B1 Compositions for treating neurodegenerative diseases
07/28/2010EP1244797B1 Translentiviral vector system
07/28/2010EP1137789B1 A method for manufacturing glycoproteins having human-type glycosylation
07/28/2010CN1904150B Human glucagon peptide/derivative and its solid phase chemical synthesis
07/28/2010CN1764469B Papanicolau staining process
07/28/2010CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
07/28/2010CN1625409B Immunogen preparation of variable peptidic epitopes and preparation method thereof
07/28/2010CN101790581A Cell carrier containing collagen
07/28/2010CN101790539A Amelioration of cellular stress response
07/28/2010CN101790538A Ucagon/glp-1 receptor co-agonists
07/28/2010CN101790537A Glycosaminoglycan-antagonising mcp-1 mutants and methods of using same
07/28/2010CN101790535A Process for the production of pramlintide
07/28/2010CN101790382A idiotypic vaccine
07/28/2010CN101787371A Chemosynthetic HSV2 virus gD glycoprotein extracellular region gene segment as well as expression and application thereof
07/28/2010CN101787078A Collagen polypeptide, preparation method and application thereof
07/28/2010CN101787077A Preparation of 131I-thyroid stimulating hormone (TSH) and application thereof
07/28/2010CN101787076A Preparation method of oxidized low-density lipoprotein and application technology thereof
07/28/2010CN101787075A Amino acid sequence with characteristic of bonding histone deacetylase 1 and expression vector thereof
07/28/2010CN101787074A Leymus chinensis aquaporin and encoding gene and application thereof
07/28/2010CN101787073A Methods and compositions for the treatment of gastrointestinal disorders
07/28/2010CN101787072A Specific binding agents of human angiopoietin-2
07/28/2010CN101229367B Process of preparing human fibrinogen preparation
07/28/2010CN101016547B Method of preparing ocean double RNA virus MABV recombination albumen and application thereof
07/27/2010US7763777 polynucleotides encoding polypeptides that are associated with abiotic stress resistance in plants, resulting in increased growth/yield under normal or drought conditions; transgenic plants
07/27/2010US7763776 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
07/27/2010US7763721 polynucleotides that code for immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts
07/27/2010US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases
07/27/2010US7763715 dissolving chitin, chitosan, elastin, collagen, keratin or plylactones in solvents, then recovering them by centrifugation, sedimentation, crystallization, decantation or filtration; solvent extraction
07/27/2010US7763714 Human NEDD8 activating enzyme 1 beta proteins and uses thereof
07/27/2010US7763713 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology
07/27/2010US7763712 Bone delivery conjugates and method of using same to target proteins to bone
07/27/2010US7763711 Consisting of the amino acid sequence SVASTITGV, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
07/27/2010US7763709 purified immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts
07/27/2010US7763707 synthetic proteins, used for the treatment and/or prevention of loss of body weight and body fat
07/27/2010US7763706 cleaving proteins by enzymatic hydrolysis into peptides, then allowing the peptides to bind to a cation exchange resin, washing the cation exchange resin with an alkaline solution and eluting bound peptides from the resin with water; active compound in drugs, nutraceutical, beverages and food products
07/27/2010US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection
07/27/2010US7763704 Chemically synthesized S3 peptide from Sushi3 domain of Factor C; endotoxin-sensitive serine protease binds, neutralizes lipopolysaccharide activity; Fluorescent tagged-S3 detects LPS-containing bacteria; pathogen-recognizing molecules, tandem multimers of the S3 gene constructed and expressed in E. coli
07/27/2010US7763591 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage)
07/27/2010US7763589 Administering a vector construct that expresses an immunogenic portion of an antigen derived from a pathogen, and administering an immunogenic protein of said antigen, to generate an immune response
07/27/2010US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods
07/27/2010US7763465 Unique novel Bacillus thuringiensis gene with lepidopteran activity
07/27/2010US7763451 Culturing, nucleotide sequence encoding antigen at pH 7 to 8, adjusting amino acid sequence by deletion and replacement of peptide in the sequence, producing antibodies in vivo, vaccination, nucleic acid construct, transgenic cells
07/27/2010US7763450 Functional influenza virus-like particles (VLPs)
07/27/2010US7763449 Bioactive ribonucleases for treating tumors in humans
07/27/2010US7763447 Method of producing succinic acid with bacterium comprising a modified fumarate reductase gene or a modified succinate dehydrogenase gene
07/27/2010US7763446 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences
07/27/2010US7763445 Dimeric fusion proteins and materials and methods for producing them
07/27/2010US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis
07/27/2010US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity
07/27/2010US7763434 monoclonal antibodies against interleukin-15(IL-15) that prevent IL-15 from effecting signal transduction through the beta - or gamma -subunits of the IL-15 receptor complex; treating transplant rejection and graft-versus-host disease
07/27/2010US7763432 monoclonal or monoclonal antibodies that binds specifically to pregnancy associated antigens, used in immunoassays for detecting pregnancy-associated glycoproteins, that are structurally related to the pepsins
07/27/2010US7763431 screening for modulators and can be used as flavor additives in compositions for human or animal consumption
07/27/2010US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria
07/27/2010US7763260 Murine calicivirus
07/27/2010US7763259 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
07/27/2010US7763258 Used to assess protein binding interactions
07/27/2010US7763256 Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
07/27/2010US7763254 Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions
07/27/2010US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
07/27/2010CA2462686C Fret protease assays for clostridial toxins
07/27/2010CA2430112C Paramyxovirus vector encoding angiogenesis gene and use thereof
07/27/2010CA2375820C The myostatin gene promoter and inhibition of activation thereof
07/27/2010CA2368944C Paramyxovirus-derived rnp
07/27/2010CA2339870C Antithrombin nucleotides and proteins from horn fly